Status:
COMPLETED
Culprit-first in Primary Percutaneous Coronary Intervention
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Coronary Artery Disease
Ischemic Heart Disease
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
The aim of this study is to assess the impact of culprit-first versus culprit-last percutaneous coronary intervention on the door to balloon time and clinical outcomes in patients with ST-elevation my...
Detailed Description
Ischemic heart disease (IHD) is the single most common cause of death and its frequency is increasing globally. It is estimated that IHD is the cause of 1.8 million deaths or 20% of all deaths in Euro...
Eligibility Criteria
Inclusion
- Patients presenting with STEMI who are eligible for PPCI
Exclusion
- Cardiac arrest
- Cardiopulmonary resuscitation or extracorporeal membrane oxygenation on arrival to the catheterization laboratory
- Prior coronary artery bypass grafting surgery
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2023
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT05415085
Start Date
May 1 2021
End Date
April 13 2023
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical Center
Jerusalem, Israel, 9103102